UK accepts healthcare AI rules for devices that keep changing
The UK government accepted all 44 recommendations from its healthcare AI commission. The programme centres on monitoring tools after they enter clinical use, clarifying responsibility across the health system and increasing transparency. Regulators plan guidance on permitted device changes and will explore staged authorisation. An implementation roadmap is due by spring 2027; acceptance begins that programme without immediately bringing every proposed rule into force.
Artificial Intelligence··Evening
Medical AI oversight continues after deployment
The UK government accepted all 44 recommendations of its National Commission into the Regulation of AI in Healthcare on 6 October. The programme addresses tools that can change after their initial assessment, putting continuing safety and performance monitoring at the centre of oversight. The decision starts implementation through guidance, consultation and possible legislation; the proposed changes have not all entered into force.[1], [2]
The Medicines and Healthcare products Regulatory Agency, the UK regulator known as MHRA, plans clearer guidance on which software qualifies as a medical device and how its intended purpose is assessed. The response also covers device classification, so the oversight route reflects the product’s function and use.[1]
Permitted changes need defined boundaries
The MHRA plans draft guidance on predetermined change control plans by December. These plans define which changes are permitted while preserving a device’s intended use. The agency will explore staged authorisation that allows earlier access while real-world evidence is gathered, alongside controlled regulatory testing environments. Continuing surveillance is intended to track safety and performance as devices are used in clinical settings.[1]
A programme board tracks delivery
The response assigns roles to manufacturers, healthcare organisations, professionals and regulators. Health departments and NHS England, England’s national health-service organisation, will work on organisational readiness and staff capabilities. A programme board including health, regulatory and research organisations and devolved administrations is planned to meet quarterly. The implementation plan and roadmap are due by spring 2027, followed by annual progress updates. The MHRA also intends a consultation on software and AI-device classification by that spring.[1]
